Peptides by condition · Brain and nerves
Peptides studied for insomnia
Checked against our study pages and the FDA labelsPublished by PepVault
Our library holds 3 study pages on insomnia: 3 in people (1 of them a meta-analysis or randomized trial). They studied one compound, DSIP.
What the research on insomnia looks like
Insomnia is trouble falling asleep or staying asleep, night after night, with tiredness the next day. The peptide research on it is old and small: a handful of trials from the last decades of the twentieth century tested DSIP, a peptide first found in the blood of rabbits put to sleep, in adults with long-standing insomnia.
These trials recorded sleep overnight in a sleep lab, with brain waves showing how long people took to fall asleep, how often they woke and how much deep sleep they got, and asked about sleep quality and daytime alertness. Some also gave tests of attention and mood the next day, because what people with insomnia often mind most is how they feel and think after a poor night.
The trials were tiny and short, a single dose or a week of doses, and their results differ: the earlier ones reported clear gains, the later placebo-controlled one only weak ones. Insomnia responds to placebo and to changes in habits, so a placebo group matters, and nights in a sleep lab say little about months at home. None of these trials followed people for long after the last dose, so whether any gain lasted is not known from them, and none of them compared synthetic DSIP head to head with the sleep medicines doctors use today.

The 3 studies, by compound
Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.
DSIP
3 in peopleFor insomnia, 3 of our study pages are filed under DSIP: 1 randomized trial and 2 clinical trials in people. The largest in people enrolled 16 people and was published in 1992. They were published from 1981 to 1992, in Neuropsychobiology, Eur Neurol and Experientia.
DSIP (emideltide) has no FDA-approved product: Drugs@FDA lists no application for it.
- Randomized trial in people · 16 people · 1992DSIP gave only weak sleep gains in 16 people with chronic insomnia
- Clinical trial in people · 14 people · 1987DSIP improved night sleep and daytime alertness in chronic insomnia
- Clinical trial in people · 6 people · 1981DSIP: longer, less interrupted sleep in 6 people with chronic insomnia
Side by side
For the compound on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).
| Compound | In people | Animals or cells | Largest in people | FDA |
|---|---|---|---|---|
| DSIP | 3 | 0 | 16 | Not approved |
- In people
- 3
- Animals or cells
- 0
- Largest in people
- 16
- FDA
- Not approved
What the studies did not show
Each study page names its own limits. These are the questions still open, in the study pages’ words.
- DSIP gave only weak sleep gains in 16 people with chronic insomniaThe trial was small, with 16 people, and short, with only 3 doses over 3 nights. It does not show what longer use would do.
- DSIP: longer, less interrupted sleep in 6 people with chronic insomniaWith only 6 people, this is a very small study, and it tested a single intravenous dose rather than repeated use. It shows nothing about long-term effects or other ways of giving DSIP.
This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.
Questions
Which peptides have been studied for insomnia?
Our 3 study pages on insomnia are all filed under one compound, DSIP.
Have any been tested in people with insomnia?
Yes: all 3 were in people, 1 of them a meta-analysis or randomized trial (DSIP). The largest enrolled 16 people: “DSIP gave only weak sleep gains in 16 people with chronic insomnia” (1992).
Is any peptide FDA-approved for insomnia?
Not by the labels our status pages read: of the one compound here with an FDA record, none has a use tied to insomnia.
How large were the studies in people on insomnia?
Of the 3 in people, all give their size on our pages: 3 had fewer than 100. The largest, a randomized trial from 1992, enrolled 16.
What is the newest study on insomnia here?
Of our study pages on insomnia, the newest is “DSIP gave only weak sleep gains in 16 people with chronic insomnia”, a randomized trial in people published in 1992.
How this page was built
A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.
Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.